186 related articles for article (PubMed ID: 27048342)
1. Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sahebkar A; Ponzo V; Bo S
Curr Med Chem; 2016; 23(13):1356-69. PubMed ID: 27048342
[TBL] [Abstract][Full Text] [Related]
2. Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis.
Liu X; Men P; Wang Y; Zhai S; Liu G
Lipids Health Dis; 2016 Nov; 15(1):204. PubMed ID: 27881129
[TBL] [Abstract][Full Text] [Related]
3. Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials.
Atkin SL; Katsiki N; Banach M; Mikhailidis DP; Pirro M; Sahebkar A
J Diabetes Complications; 2017 Sep; 31(9):1458-1464. PubMed ID: 28647512
[TBL] [Abstract][Full Text] [Related]
4. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.
Chruściel P; Sahebkar A; Rembek-Wieliczko M; Serban MC; Ursoniu S; Mikhailidis DP; Jones SR; Mosteoru S; Blaha MJ; Martin SS; Rysz J; Toth PP; Lip GY; Pencina MJ; Ray KK; Banach M;
Atherosclerosis; 2016 Oct; 253():194-208. PubMed ID: 27498397
[TBL] [Abstract][Full Text] [Related]
5. Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings
.
Kostev K; Schokker E; Jacob L
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):411-416. PubMed ID: 30049306
[TBL] [Abstract][Full Text] [Related]
6. Effects of dipeptidyl peptidase-4 inhibitors on beta-cell function and insulin resistance in type 2 diabetes: meta-analysis of randomized controlled trials.
Lyu X; Zhu X; Zhao B; Du L; Chen D; Wang C; Liu G; Ran X
Sci Rep; 2017 Mar; 7():44865. PubMed ID: 28322294
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Luo Y; Lu K; Liu G; Wang J; Laurent I; Zhou X
Clin Drug Investig; 2018 Dec; 38(12):1089-1108. PubMed ID: 30255388
[TBL] [Abstract][Full Text] [Related]
8. The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.
Yang J; Huang C; Wu S; Xu Y; Cai T; Chai S; Yang Z; Sun F; Zhan S
PLoS One; 2017; 12(12):e0187537. PubMed ID: 29206832
[TBL] [Abstract][Full Text] [Related]
9. Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.
Sahebkar A; Watts GF
Atherosclerosis; 2013 Sep; 230(1):110-20. PubMed ID: 23958262
[TBL] [Abstract][Full Text] [Related]
10. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sahebkar A; Beccuti G; Simental-Mendía LE; Nobili V; Bo S
Pharmacol Res; 2016 Apr; 106():37-50. PubMed ID: 26875640
[TBL] [Abstract][Full Text] [Related]
11. Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysis.
Derosa G; Maffioli P; Sahebkar A
Br J Clin Pharmacol; 2016 May; 81(5):819-34. PubMed ID: 26717446
[TBL] [Abstract][Full Text] [Related]
12. Effect of dipeptidyl-peptidase-4 inhibitors on C-reactive protein in patients with type 2 diabetes: a systematic review and meta-analysis.
Liu X; Men P; Wang B; Cai G; Zhao Z
Lipids Health Dis; 2019 Jun; 18(1):144. PubMed ID: 31208420
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: a systematic review and meta-analysis.
Sahebkar A
Metabolism; 2013 Dec; 62(12):1876-85. PubMed ID: 24095632
[TBL] [Abstract][Full Text] [Related]
14. The effect of curcumin supplementation on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials.
Clark CCT; Ghaedi E; Arab A; Pourmasoumi M; Hadi A
Diabetes Metab Syndr; 2019; 13(5):2819-2825. PubMed ID: 31425942
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of the efficacy of glucose control, lipid profile, and β-cell function between DPP-4 inhibitors and AGI treatment in type 2 diabetes patients: a meta-analysis.
Cai X; Yang W; Zhou L; Zhang S; Han X; Ji L
Endocrine; 2015 Dec; 50(3):590-7. PubMed ID: 26048437
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.
Cai L; Cai Y; Lu ZJ; Zhang Y; Liu P
J Clin Pharm Ther; 2012 Aug; 37(4):386-98. PubMed ID: 22191695
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials.
Mohammadi-Sartang M; Mazloom Z; Sohrabi Z; Sherafatmanesh S; Barati-Boldaji R
Pharmacol Res; 2017 Mar; 117():394-405. PubMed ID: 28089943
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
Wu S; Chai S; Yang J; Cai T; Xu Y; Yang Z; Zhang Y; Ji L; Sun F; Zhan S
Clin Ther; 2017 Sep; 39(9):1780-1789.e33. PubMed ID: 28827024
[TBL] [Abstract][Full Text] [Related]
19. Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials.
Simental-Mendía LE; Sánchez-García A; Linden-Torres E; Simental-Mendía M
Br J Clin Pharmacol; 2021 Nov; 87(11):4140-4149. PubMed ID: 33835520
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis.
Men P; He N; Song C; Zhai S
Diabetes Metab; 2017 Dec; 43(6):493-500. PubMed ID: 28778563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
